Nephros (NEPH) Return on Capital Employed Growth (1y) (2012 - 2026)
Nephros (NEPH) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 395.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 62.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 82.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 142.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -203.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 1,267.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -128.00 |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | -169.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -169.00 |
| Dec 31, 2025 | 1,067.00 |
| Sep 30, 2025 | 2,397.00 |
| Jun 30, 2025 | 2,777.00 |
| Mar 31, 2025 | 2,305.00 |
| Dec 31, 2024 | 1,724.00 |
| Sep 30, 2024 | 864.00 |
| Jun 30, 2024 | 1,399.00 |
| Mar 31, 2024 | 1,709.00 |
| Dec 31, 2023 | 2,727.00 |
| Sep 30, 2023 | 1,908.00 |
| Jun 30, 2023 | 88.00 |
| Mar 31, 2023 | -419.00 |
| Dec 31, 2022 | -2,060.00 |
| Sep 30, 2022 | -1,490.00 |
| Jun 30, 2022 | -561.00 |
| Mar 31, 2022 | -284.00 |
| Dec 31, 2021 | 365.00 |
| Sep 30, 2021 | 562.00 |
| Jun 30, 2021 | 58.00 |